Genentech, Novartis Sued Over Asthma Drug Patent - Law360

Genentech, Novartis Sued Over Asthma Drug Patent – Law360

Source Node: 2878212
By Hanna Vioque (September 13, 2023, 6:31 PM BST) — Celltrion Healthcare has urged a London court to invalidate a patent for a drug used to treat severe asthma and chronic hives belonging to Swiss pharma giant Novartis and California-based Genentech, as it prepares to launch a biosimilar rival….

Time Stamp:

More from Law 360